Mark Pruzanski Intercept Pharmaceuticals CEO Rating
Where This Score Ranks Intercept Pharmaceuticals' CEO Rating
- TOP5%
In the Top 5% of 1832 Similar Sized Companies on Comparably
- TOP5%
In the Top 5% of 707 Nearby Companies in New York
- 1st
1st place versus 4 competitors rated on Comparably
Intercept Pharmaceuticals CEO Mark Pruzanski Bio
Mark Pruzanski serves as the CEO / President of Intercept Pharmaceuticals.
Intercept Pharmaceuticals CEO Mark Pruzanski At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Intercept Pharmaceuticals.
Based on 4 ratings, Mark Pruzanski ranks right above Aptalis Pharma's CEO, Brenton Saunders.
Overall, the CEO score has remained stable over the last 90 days.
Intercept Pharmaceuticals CEO Mark Pruzanski Rating Trendline
- Intercept Pharmaceuticals
- Other Companies in New York66
- Similar Size on Comparably64
Intercept Pharmaceuticals' CEO Rating Rank Against Similar Sized Companies on Comparably
Intercept Pharmaceuticals ranks in the Top 5% of other companies on Comparably with 501-1,000 Employees for CEO Rating Score.
Intercept Pharmaceuticals' CEO Rating Rank Against Other Companies Nearby
Intercept Pharmaceuticals ranks in the Top 5% of other companies in New York for CEO Rating Score.
Questions Recently Asked asked Intercept Pharmaceuticals
